Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cryopreserved Erythrocytes Processed for Blood Transfusion

By LabMedica International staff writers
Posted on 10 Apr 2012
Cryostorage of red blood cells (RBCs) represents a valid alternative to liquid storage, since units can be preserved safely for at least a decade while conserving cell viability.

Preservation of blood for transfusion purposes has represented a lifesaving advance in clinical practice over many years, but although cryostorage has attracted a great deal of attention clinically, little is known about the biochemistry and physiology of cryostored erythrocyte concentrates. More...


Specialists at the University of Tuscia (Viterbo, Italy) investigated cryostorage of RBCs through monitoring of cell processing steps, from fresh blood, to glycerolization, thawing, and deglycerolization, followed by washing. Whole blood was collected from 10 healthy donor volunteers into 63 mL of citrate phosphate dextrose (CPD) anticoagulant, and leukodepleted. All glycerolized RBC units were frozen and stored at −80 ± 10 °C in a mechanical freezer for at least 12 months.

The erythrocytes were monitored through repeated assays of standard parameters of mean cell volume (MCV), red cell distribution width-standard deviation (RDW-SD), the mean cell hemoglobin concentration (MCHC), and the hematocrit (Hct). These were determined with a CA 530-Oden hematology analyzer. Scanning electron microscopy was also performed. Other standard biological indicators, such as hemoglobin content, pH values both internal and in the supernatant, lactate levels, osmotic fragility and hemolysis, were also calculated.

Cell processing for cryostorage resulted in increased RBC volumes. Mean cell volume (MCV) increased significantly upon glycerolization, from 89.4 ± 4.5 fL of fresh RBCs to 126.04 ± 2.3 fL of glycerolized RBCs, while it remained constant at 129.6 ± 3.3 fL upon cryostorage even after thawing. Deglycerolization and washing restored lower MCV values 93.7 ± 5.9 fL, though they were still higher than controls. Shape alterations caused an increase in osmotic fragility and permeability to ions. A significant pH drop was observed which could not to be attributed to a higher metabolic rate, since the levels of lactate did not show substantial fluctuation during the cell processing steps tested in this study. The membrane anomalies reported are likely related to the hemolysis observed which preferentially affected the densest and oldest cell sub-populations, as confirmed by means of discontinuous density gradients. The CA 530-Oden hematology analyzer used in the study is manufactured by Medonic (Stockholm, Sweden).

The authors concluded that their results indicate that cryostorage itself in presence of glycerol does not significantly affect RBCs. Most of the alterations observed were related to cell processing and, in particular, to the increase of cytosolic glycerol as a consequence of the glycerolization step. Further studies might profitably investigate replacing glycerol with nonpenetrating cryoprotectants such as polyvinylpyrrolidone or polyethylene glycol, or the less toxic sucrose and trehalose.The study was published online on March 14, 2012, in the journal Blood Cells, Molecules, and Diseases.

Related Links:

University of Tuscia
Medonic



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.